Telecobalt therapy for prostatic cancer: rationale, results and future considerations

M. McLoughlin, T. Hazra, H. K.A. Schirmer, W. W. Scott

Research output: Contribution to journalArticle

Abstract

External supervoltage radiation is now an accepted form of treatment for adenocarcinoma of the prostate, but the tumor response cannot be predicted. It is hoped that accurate clinical staging coupled with a biological staging of the tumor cells with catalase activity will enable one to predict this response. Ionizing radiations act by producing active radicals, hence the rationale of studying the tissue catalase activity in conjunction with the histological grading may provide a more accurate index of patients who would gain the most benefit from radiotherapy.

Original languageEnglish (US)
Pages (from-to)378-379
Number of pages2
JournalJournal of Urology
Volume113
Issue number3
DOIs
StatePublished - Jan 1 1975

    Fingerprint

ASJC Scopus subject areas

  • Urology

Cite this